Business / Finance

RSS

Two existing clinical stage clients expand development activities with Progenitor Cell Therapy

Progenitor Cell Therapy (PCT), an internationally recognized cell therapy services and development company, and a wholly-owned subsidiary of NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that two existing clinical stage biopharmaceutical corporate clients have chosen to expand their development activities with PCT.

18 Jul 2011

Labopharm reduces workforce, expects to save $2.7 million annually

Labopharm Inc. today announced that it has further reduced its workforce, eliminating 23 positions. Following the reduction, Labopharm will have 71 employees to support its continuing operations.

18 Jul 2011

Shionogi to acquire Victory Pharma's products to treat pain and infectious diseases

Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced that it has entered into an agreement to acquire all currently marketed products from Victory Pharma, Inc., including seven treatments for pain and two for infectious diseases. The products, which are all approved by the Food and Drug Administration (FDA), will be marketed by Shionogi's existing sales force.

18 Jul 2011

Thermo Fisher Scientific announces acquisition of TREK Diagnostic Systems

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has acquired TREK Diagnostic Systems, a global provider of microbiology solutions, including blood culture, microorganism identification and antibiotic susceptibility testing (AST) products, from Magellan Biosciences. Based near Cleveland, Ohio, the company had full year revenue in 2010 of $34 million and has 150 employees.

From Thermo Fisher Scientific Inc. 18 Jul 2011

WebMD anticipates 15% increase in revenue for second quarter 2011

WebMD Health Corp., the leading source of health information, today announced preliminary financial results for the three months ended June 30, 2011 and updated financial guidance for 2011.

18 Jul 2011

NSVascular signs exclusive license with UCLA for Thin-Film Nitinol technology

NeuroSigma, Inc., a Los Angeles-based medical device company, today announced the formation of a majority owned subsidiary, NSVascular, Inc. and the signing of an exclusive license with the University of California, Los Angeles (UCLA) covering its medical applications of Thin-Film Nitinol (TFN) technology. Nitinol is a superelastic nickel and titanium alloy with unique properties that allow deformation and subsequent full recovery of the original shape upon exposure to body heat.

18 Jul 2011

Bacterin forays into medical devices with acquisition of Robinson MedSurg

Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and anti-infective coatings for medical applications, has acquired the assets of Robinson MedSurg LLC (RMS), a medical device distribution company focused primarily on maxillofacial and craniofacial surgery devices.

18 Jul 2011

Endologix, LeMaitre Vascular announce early termination agreement for aortic endovascular products in Europe

Endologix, Inc., developer and marketer of minimally invasive treatments for aortic disorders, and LeMaitre Vascular, Inc., provider of peripheral vascular devices and implants, announced today that the companies have entered into an early termination agreement for LeMaitre's distribution rights of Endologix's aortic endovascular products in Europe.

18 Jul 2011

LabCorp extends expiration of tender offer for Orchid Cellmark common stock

Laboratory Corporation of America Holdings today announced that LabCorp is extending until 5:00 p.m., New York City time, on August 12, 2011, LabCorp's previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc.

18 Jul 2011

Intelsius, American Thermal Instruments enter strategic partnership

Intelsius, a global manufacturer and distributor of environmentally sustainable, temperature-controlled and regulatory-compliant packaging solutions, announces a strategic partnership with American Thermal Instruments (ATI), a leader in temperature monitoring, inspections and asset tracking.

18 Jul 2011

Aetna enters agreement to acquire account-based health plan administrator, PayFlex

Aetna today announced that it has entered into an agreement to acquire PayFlex Holdings, Inc., one of the nation's largest independent account-based health plan administrators, with approximately 1 million accounts and approximately 3,300 direct employer customers.

18 Jul 2011

Cell Biosciences is now ProteinSimple

Cell Biosciences, Inc. today announced that it has changed its name to ProteinSimple to clearly reflect the Company's core mission in protein research.

From ProteinSimple 18 Jul 2011

Sofinnova Ventures leads $44 million Series B private equity financing for SARcode Bioscience

SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing. The financing round was led by Sofinnova Ventures and was augmented by the additional backing of Rho Ventures and existing investors Alta Partners and Clarus Venture Partners.

18 Jul 2011

Transcept decreases workforce following FDA news on Intermezzo NDA

Transcept Pharmaceuticals, Inc. announced today plans to reduce operating expenses by eliminating approximately 45% of its workforce following notification from the U.S. Food and Drug Administration (FDA) that the resubmitted New Drug Application (NDA) for Intermezzo, the company's lead product candidate, cannot be approved in its present form.

16 Jul 2011

Guizhou Provincial Health Department issues 'Revised Plan' for blood collection stations

China Biologic Products, Inc., a leading plasma-based biopharmaceutical company in China, today announced that the Guizhou Provincial Health Department has issued the revised "Plan for Guizhou Provincial Blood Collection Institutional Setting."

16 Jul 2011

Successful strategies for launching fixed dose combination products to market

The pharmaceutical industry is under constant pressure to produce new products and fixed dose combination therapies are one of the industry's strategies to offset lackluster pipelines and patent loss.

16 Jul 2011

Valeant to acquire Ortho Dermatologics

Valeant Pharmaceuticals International, Inc. announced today that Valeant's subsidiaries, Valeant Pharmaceuticals North America LLC (VPNA) and Valeant International (Barbados) SRL (VIB), have signed an agreement to acquire the assets of the Ortho Dermatologics division of Janssen Pharmaceuticals, Inc.

16 Jul 2011

Champions Oncology revenue increases 41% to $6.9 million for fiscal 2011

For its fiscal year 2011, Champions generated revenue of $6.9 million, an increase of $2 million or 41%, compared to fiscal year 2010.

16 Jul 2011

Medical Properties Trust announces results of cash tender offer for MPT Operating Partnership

Medical Properties Trust, Inc. and MPT Operating Partnership, L.P. today announced the expiration and final results of the previously announced cash tender offer to purchase any and all of the outstanding 9.25% Exchangeable Senior Notes due 2013 (CUSIP Number 55342NAG5) issued by the Operating Partnership at a purchase price of $1,185.29 for each $1,000 principal amount of the exchangeable notes purchased pursuant to the tender offer, plus accrued and unpaid interest to, but not including, the date of payment.

15 Jul 2011

First round of financing could make the intelligent bed a reality

At the end of May 2011, two "business angels" and a banking institute invested one million Swiss francs in Michael Sauter's company -compliant concept-. The successful end to this first round of financing is a milestone for the mechanical engineer and young entrepreneur. "This means that the intelligent bed can now become a reality," he says, joyfully.

15 Jul 2011